Cannabix首席科学官11月13日在温哥华会议报告多药呼气检测：可检出THC、安非他明、可卡因与阿片类药物
呼气检测技术公司 Cannabix Technologies 于 2026 年 11 月 13 日宣布，其首席科学官 Raj Attariwala 博士将在当天于温哥华举行的不列颠哥伦比亚省物质使用障碍卓越中心会议上，报告公司新近的多药呼气检测技术。
公司称，近期研究结果显示，其多药呼气检测平台能够在呼气中检出 delta-9 THC 以及其他违禁药物，包括安非他明与甲基安非他明、可卡因，以及芬太尼等阿片类药物的痕迹。
公司表示，这些结果显示其呼气采集单元平台作为标准化呼气采集技术的更广泛潜力，可支持未来的多分析物检测方法与科学呼气研究项目。
公司资料显示，Cannabix 开发基于呼气的技术，产品包括针对 delta-9 THC 等物质的大麻呼气检测，以及无人值守酒精筛查方案 BreathLogix，应用场景包括工作场所与执法等场合。
（来源：Cannabix Technologies）
Cannabix Chief Scientific Officer Presents Multi-Drug Breath Testing in Vancouver on November 13: The Platform Detected THC, Amphetamines, Cocaine and Opioids Such as Fentanyl
Breath testing technology company Cannabix Technologies announced on November 13, 2026 that its chief scientific officer, Dr. Raj Attariwala, would present the company's emerging multi-drug breath testing technology at the BC Centre for Excellence conference on substance use disorder, held in Vancouver, British Columbia on November 13. The company said recent findings demonstrate the ability of its Multi-Drug Breath Test platform to detect delta-9 THC and other illicit drugs in breath, including traces of amphetamines and methamphetamines, cocaine, and opioids such as fentanyl. The company said the findings highlight the broader potential of its Breath Collection Unit platform as a standardized breath collection technology that could support future multi-analyte testing approaches and scientific breath initiatives. Company information describes Cannabix as a developer of breath-based technologies for workplaces, law enforcement and other settings, including a marijuana breath test targeting delta-9 THC and the BreathLogix unmanned alcohol screening solution.
(Source: Cannabix Technologies)
来源：Cannabix Technologies
发布：GSM·美国（发布链接）
图片来源：图：执法人员进行呼气酒精检测。Oregon Department of Transportation，CC BY 2.0，经 Wikimedia Commons。 / Photo: Oregon Department of Transportation, CC BY 2.0, via Wikimedia Commons.
GSM Global · 本篇英文版 English edition of this story
